AstraZeneca COVID-19 vaccine trial's volunteer dies, testing
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A volunteer participating in clinical trials of the COVID-19 vaccine developed by Oxford University has died in Brazil, officials announced, though media reports said he had received a placebo, not the test vaccine.

It is the first death reported in the various coronavirus vaccine trials taking place worldwide.

However, organizers of the study said an independent review had concluded there were no safety concerns and that testing of the vaccine, developed with pharmaceutical firm AstraZeneca, would continue.

Media reports said the volunteer was a 28-year-old doctor working on the front lines of the pandemic who died of complications from COVID-19.

Brazilian newspaper Globo and international news agency Bloomberg said he was in the control group and had received a placebo rather than the test vaccine, citing sources close to the trials.

"Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial, and the independent review in addition to the Brazilian regulator have recommended that the trial should continue," Oxford said in a statement.

Source: https://www.firstpost.com/world/volunteer-in-oxford-astrazeneca-covid-19-vaccine-trial-dies-in-brazil-officials-say-testing-to-continue-8939701.html
Dr. T●●●●z H●●●●●●i and 2 other likes this4 shares
Like
Comment
Share